Does ketoconazole really help with hair loss?
← back to Ketoconazole
Does Ketoconazole Really Help with Hair Loss?
Hair loss is a common concern affecting both men and women around the world. Among the most discussed and recommended treatments is ketoconazole, an antifungal used primarily to treat scalp infections such as seborrheic dermatitis and dandruff. However, in recent years, it has gained popularity as a possible solution for androgenetic alopecia. But does it really work? To what extent can it help in preventing and reversing hair loss?
Ketoconazole: Much more than an antifungal
Ketoconazole is a drug belonging to the imidazole family. Topical forms, such as shampoo and cream, are approved in the US and EU to treat fungal skin and scalp conditions. Its shampoo formulation (such as the widely known Nizoral) is used to combat dandruff, reduce inflammation and relieve itchy scalp. However, its potential to slow hair loss and stimulate hair growth has sparked the interest of researchers and dermatology specialists.
The theory behind the use of ketoconazole for androgenetic alopecia lies in its ability to reduce inflammation and possibly inhibit the effects of dihydrotestosterone (DHT), a hormone linked to the miniaturization of hair follicles. DHT is a byproduct of testosterone and is primarily responsible for hair loss in people with a genetic predisposition to baldness.
It has been proposed that ketoconazole could improve scalp microcirculation and promote the anagen phase (growth phase) of hair, although its exact mechanism is still under study. The combination of these effects makes it an interesting adjunctive treatment for those seeking to combat hair loss.
How Does Ketoconazole Work on Hair?
Ketoconazole comes as a shampoo, a cream and oral tablets. Only the shampoo is discussed as a possible aid for hair loss, and it is not approved for that use. Everything on this page about hair refers to the 1–2% shampoo.
Topical Ketoconazole
The most commonly used form of ketoconazole in the treatment of alopecia is shampoo with concentrations of 1% or 2%. It is applied directly to the scalp, leaving it to act for a few minutes before rinsing. It is thought to act by reducing inflammation and sebum on the scalp, which may make the scalp a more favourable environment for hair, though this has not been shown to change pattern hair loss. A small 1998 study reported improved hair density and a higher share of growing (anagen) follicles with regular 2% shampoo use, and a 2020 systematic review found only five human studies (318 participants in total) and called for randomised controlled trials (Piérard-Franchimont et al., 1998; Fields et al., 2020).
Oral Ketoconazole
Oral ketoconazole tablets are not a hair-loss treatment. In the US they carry a boxed warning for serious liver injury, including deaths and liver transplants, and for dangerous heart-rhythm (QT prolongation) problems when taken with certain other medicines. The label limits them to serious fungal infections when other antifungal treatment is not available or not tolerated (DailyMed, ketoconazole tablets). In 2013 the European Medicines Agency recommended suspending oral ketoconazole for fungal infections across the EU because the risk of liver injury outweighed the benefit (EMA, 26 July 2013).
What the Research Says
There are key studies that have evaluated the impact of ketoconazole on hair loss. A 1998 study published in Dermatology compared 2% ketoconazole shampoo with an unmedicated shampoo, used with or without 2% minoxidil, in people with androgenetic alopecia. The authors reported that hair density, hair size and the proportion of growing (anagen) follicles improved almost as much with the ketoconazole regimen as with the minoxidil regimen. This small study does not show that the two are equally effective, and the authors said the results needed a larger controlled study (Piérard-Franchimont et al., 1998).
A 2020 systematic review found five human studies with 318 participants in total. The authors called topical ketoconazole a promising add-on or alternative therapy but said randomised controlled trials are needed (Fields et al., 2020).
User Reviews
While scientific studies provide an objective view on ketoconazole, user experiences can offer a more practical perspective on its effectiveness. In the Reddit community r/tressless, where many people share their experiences with hair loss treatments, ketoconazole is a recurring topic.
Some users report that consistent use of 2% ketoconazole shampoos has noticeably improved the health of their scalp and reduced hair loss, especially when combined with other treatments such as minoxidil and finasteride. One user documented her progress over a year using ketoconazole along with minoxidil and finasteride, and reported improvement in her hair density and thickness. Finasteride is not approved for women and must not be used by women who are or may become pregnant; any use in women is off-label and needs a prescriber. In another testimonial, a user with female androgenetic alopecia mentioned that ketoconazole helped her control scalp inflammation and itchiness, although she did not notice significant new hair growth.
However, there are also mixed reviews. Some users claim they did not experience visible improvements in hair density, although they acknowledge that ketoconazole helped control dandruff and excessive oiliness. Others mention side effects such as dryness of the scalp or irritation, especially at the beginning of treatment.
References
Piérard-Franchimont, C., De Doncker, P., Cauwenbergh, G., & Piérard, G. E. (1998). Ketoconazole shampoo: Effect of long-term use in androgenic alopecia. Dermatology, 196(4), 474–477. https://doi.org/10.1159/000017954
Fields, J. R., Vonu, P. M., Monir, R. L., & Schoch, J. J. (2020). Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review. Dermatologic Therapy, 33(1), e13202. https://pubmed.ncbi.nlm.nih.gov/31858672/
DailyMed. Ketoconazole tablets, prescribing information (boxed warning). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d4be760-c723-4f54-a854-12c61cf91703
European Medicines Agency. (2013, July 26). European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-suspension-marketing-authorisations-oral-ketoconazole
(2015, September 26). Is there any way to know for sure if hair... https://www.reddit.com/r/tressless/comments/3ndh7t/is_there_any_way_to_know_for_sure_if_hair/
Has anyone here with female pattern baldness had... https://www.reddit.com/r/tressless/comments/1gdmkx6/has_anyone_here_with_female_pattern_baldness_had/
. (2023, May 5). 1 year of minfinketoconazole
https://www.reddit.com/r/tressless/comments/1c2ggkr/1_year_of_minfinketoconazole/
Varothai, S., & Bergfeld, W. F. (2014). Androgenetic alopecia: an evidence-based treatment update. American Journal of Clinical Dermatology, 15(3), 217-230. https://doi.org/10.1007/s40257-014-0077-5
Pérez, H. (2004). Ketoconazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. Medical Hypotheses, 62(1), 112-115. https://doi.org/10.1016/s0306-9877(03)00264-0